Hospice News February 27, 2025
Holly Vossel

Florida-based VITAS Healthcare is anticipating fruitful hospice growth on its horizon. The Chemed Corp. (NYSE: CHE) subsidiary has seen record-highs in patient census volumes and is ramping up strategic plans to expand its geographic footprint across its home state.

Acquisitions and de novos will make up an important mix of VITAS’ expansion, Chairman and CEO Nick Westfall said in Thursday’s earnings call. The company is optimistic about future opportunities in the Southeast, executives indicated.

“We’ve demonstrated the ability to partner with and successfully integrate other providers through acquisitions to ensure communities continue to receive the best possible patient care,” Westfall said. “As a result of these efforts, VITAS achieved all-time highs in [average daily census (ADC)] growth, revenue growth, EBITDA...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Post-Acute Care, Provider
Amedisys Sees Hospice Growth as DOJ-UnitedHealth Group Lawsuit Looms
Hospice Leaders ‘Scratching the Surface’ of Public Awareness Opportunities in 2025
What the Recent Bridge, Artemis Acquisition Plans Mean for Senior Living M&A in 2025
House Budget Vote A Step Toward Medicaid Cuts Feared By Home Care Providers
NHI Targets More SHOP Growth in 2025, With ‘Good Momentum’ Thus Far

Share This Article